The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 17 results:
Author Title Type [ Year(Asc)]
Filters: Author is Petridis, Dimitris  [Clear All Filters]
2020
Zarogoulidis, P., Christakidis V., Petridis D., Sapalidis K., Kosmidis C., Vagionas A., et al. (2020).  Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.. Expert Rev Respir Med.
Zarogoulidis, P., Petridis D., Sapalidis K., Tsakiridis K., Baka S., Vagionas A., et al. (2020).  Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.. J Cancer. 11(21), 6454-6459.
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
2019
Sapalidis, K., Zarogoulidis P., Petridis D., Kosmidis C., Fyntanidou B., Tsakiridis K., et al. (2019).  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE.. J Cancer. 10(20), 4739-4746.
Sapalidis, K., Zarogoulidis P., Petridis D., Kosmidis C., Fyntanidou B., Tsakiridis K., et al. (2019).  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE ®. Journal of Cancer. 10(20), 4739 - 4746.
2015
Zarogoulidou, V., Panagopoulou E., Papakosta D., Petridis D., Porpodis K., Zarogoulidis K., et al. (2015).  Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.. J Thorac Dis. 7(Suppl 1), S12-9.
Kallianos, A., Zarogoulidis P., Ampatzoglou F., Trakada G., Gialafos E., Pitsiou G., et al. (2015).  Reduction of exercise capacity in sarcoidosis in relation to disease severity.. Patient Prefer Adherence. 9, 1179-88.
2014
Petridis, D., Zarogoulidis P., Kallianos A., Kioumis I., Trakada G., Spyratos D., et al. (2014).  Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.. Ther Clin Risk Manag. 10, 77-86.
Huang, H., Zarogoulidis P., Lampaki S., Organtzis J., Petridis D., Porpodis K., et al. (2014).  Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.. J Thorac Dis. 6(10), 1411-9.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Pitsiou, G., Zarogoulidis P., Petridis D., Kioumis I., Lampaki S., Organtzis J., et al. (2014).  Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.. Drug Des Devel Ther. 8, 1753-63.
Tsiouda, T., Zarogoulidis P., Petridis D., Pezirkianidis N., Kioumis I., Yarmus L., et al. (2014).  A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.. J Cancer. 5(6), 433-45.
Zarogoulidis, P., Kioumis I., Lampaki S., Organtzis J., Porpodis K., Spyratos D., et al. (2014).  Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.. Drug Des Devel Ther. 8, 1065-72.
2013
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Kioumis I., Porpodis K., et al. (2013).  Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.. Int J Pharm. 456(2), 325-31.
Zarogoulidis, P., Kioumis I., Ritzoulis C., Petridis D., Darwiche K., Porpodis K., et al. (2013).  New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.. Int J Pharm. 455(1-2), 182-8.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.